An expert panel assessment of comprehensive medication reviews for clients of community mental health teams

Social Psychiatry and Psychiatric Epidemiology

Volumn 45, Issue 11, 2010, Pages 1071-1079

  Gisev, Natasa ^a   Bell, J Simon ^a,b   O'Reilly, Claire L ^a   Rosen, Alan ^a,c,d   Chen, Timothy F ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c Greater Western Area Health Service   (Australia)

^d UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Community mental health services; Community pharmacy services; Medication review; Medicines management; Psychotropic drugs

Indexed keywords

PSYCHOTROPIC AGENT;

ARTICLE; AUSTRALIA; COMMUNITY MENTAL HEALTH CENTER; COMPARATIVE STUDY; DRUG USE; EXPERT WITNESS; FEMALE; HUMAN; MALE; MEDICATION THERAPY MANAGEMENT; MENTAL DISEASE; METHODOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PHARMACIST; PHARMACY; PSYCHOLOGICAL ASPECT; STANDARD; STATISTICS;

AUSTRALIA; COMMUNITY MENTAL HEALTH CENTERS; COMMUNITY PHARMACY SERVICES; DRUG UTILIZATION REVIEW; EXPERT TESTIMONY; FEMALE; HUMANS; MALE; MEDICATION THERAPY MANAGEMENT; MENTAL DISORDERS; MIDDLE AGED; PHARMACISTS; PSYCHOTROPIC DRUGS;

EID: 78049434144     PISSN: 09337954     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00127-009-0148-8     Document Type: Article

References (47)

1. Australian Institute of Health and Welfare (2008) Mental health services in Australia 2006-2007. http://www.aihw.gov.au/publications/index.cfm/title/ 10686 Accessed 14 September 2009
2. TRE Barnes C Paton M-R Cavanagh E Hancock DM Taylor 2007 A UK audit of screening for the metabolic side effects of antipsychotics in community patients Schizophr Bull 33 1397 1403 10.1093/schbul/sbm038 17483101 (Pubitemid 350022774)
3. DW Bates DJ Cullen N Laird, et al. 1995 Incidence of adverse drug events and potential adverse drug events: implications for prevention JAMA 274 29 34 1:STN:280:DyaK2MzhtFemtw%3D%3D 10.1001/jama.274.1.29 7791255
4. JS Bell A Rosen P Aslani P Whitehead TF Chen 2007 Developing the role of pharmacists as members of community mental health teams: perspectives of pharmacists and mental health professionals Res Social Adm Pharm 3 392 409 18082875
5. JS Bell P Whitehead P Aslani AJ McLachlan TF Chen 2006 Drug-related problems in the community setting: pharmacists' findings and recommendations for people with mental illnesses Clin Drug Investig 26 415 425 10.2165/00044011- 200626070-00003 17163274 (Pubitemid 43927055)
6. JS Bell P Whitehead P Aslani S Sacker TF Chen 2006 Design and implementation of an educational partnership between community pharmacists and consumer educators in mental health care Am J Pharm Educ 70 28 17149408
7. S Bell AJ McLachlan P Aslani P Whitehead TF Chen 2005 Community pharmacy services to optimise the use of medications for mental illness: a systematic review Aust New Zealand Health Policy 2 29 10.1186/1743-8462-2-29 16336646 (Pubitemid 44848541)
8. Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Erlbaum, New Jersey, pp 75-83
9. Ellitt GR, Brien JA, Aslani P, Chen TF (2009) Quality patient care and pharmacists' role in its continuity-a systematic review. Ann Pharmacother 43:677-691
10. MA Ewan RJ Greene 2001 Evaluation of mental health care interventions made by three community pharmacists-a pilot study Int J Pharm Pract 9 225 234
11. AL Gilbert EE Roughead J Beilby K Mott JD Barratt 2002 Collaborative medication management services: improving patient care Med J Aust 177 189 192 12175322
12. N Gisev JS Bell AJ McLachlan M Chetty TF Chen 2006 Psychiatric drug use among patients of a community mental health service: patterns and implications Dis Manag Health Outcomes 14 369 376 10.2165/00115677-200614060-00006 (Pubitemid 46121355)
13. D Harris C Anderson 2003 Interventions by community pharmacists for older people with mental health problems: are they appropriate? [abstract] Int J Pharm Pract 11 R56
14. GM Hawksworth AJ Corlett DJ Wright H Chrystyn 1999 Clinical pharmacy interventions by community pharmacists during the dispensing process Br J Clin Pharmacol 47 695 700 1:STN:280:DyaK1Mzhs1ahtw%3D%3D 10.1046/j.1365-2125.1999. 00964.x 10383549 (Pubitemid 29257669)
15. Heiman GW (2001) Understanding research methods and statistics: an integrated introduction for psychology, 2nd edn. Houghton Mifflin, Boston, pp 257-262
16. R Holland E Lenaghan I Harvey, et al. 2005 Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial Br Med J 330 292 298 10.1136/bmj.38338.674583.AE (Pubitemid 40203647)
17. Institute of Medicine (2000) To err is human: building a safer health system
18. PJ Kaboli AB Hoth BJ McClimon JL Schnipper 2006 Clinical pharmacists and inpatient medical care: a systematic review Arch Intern Med 166 955 964 10.1001/archinte.166.9.955 16682568
19. I Krass C Smith 2000 Impact of medication regimen reviews performed by community pharmacists for ambulatory patients with general medical practitioners Int J Pharm Pract 8 111 120
20. J Krska AJ Avery Community Pharmacy Medicines Management Project Evaluation Team 2008 Evaluation of medication reviews conducted by community pharmacists: a quantitative analysis of documented issues and recommendations Br J Clin Pharmacol 65 386 395 1:STN:280:DC%2BD1c7ksVSqtQ%3D%3D 10.1111/j.1365-2125.2007.03022.x 17922887 (Pubitemid 351316911)
21. ID Maidment P Lelliott C Paton 2006 Medication errors in mental healthcare: a systematic review Qual Saf Health Care 15 409 413 10.1136/qshc.2006.018267 17142588 (Pubitemid 46025151)
22. K Mann JM Rothschild CA Keohane JA Chu DW Bates 2008 Adverse drug events and medication errors in psychiatry: methodological issues regarding identification and classification World J Biol Psychiatry 9 24 33 10.1080/15622970601178056 17853253 (Pubitemid 351250517)
23. B Mannheimer J Ulfvarson S Eklof, et al. 2006 Drug-related problems and pharmacotherapeutic advisory intervention at a medicine clinic Eur J Clin Pharmacol 62 1075 1081 10.1007/s00228-006-0214-z 17066294 (Pubitemid 44786500)
24. D Meagher M Moran 2003 Sub-optimal prescribing in an adult community mental health service: prevalence and determinants Psychiatr Bull 27 266 270 10.1192/pb.27.7.266 (Pubitemid 36826728)
25. AJ Mitchell 2007 Adherence behaviour with psychotropic medication is a form of self-medication Med Hypotheses 68 12 21 10.1016/j.mehy.2006.07.005 16996228
26. S Morcos S-A Francis C Duggan 2002 Where are the weakest links? A descriptive study of discrepancies in prescribing between primary and secondary sectors of mental health service provision Psychiatr Bull 26 371 374 10.1192/pb.26.10.371 (Pubitemid 35153551)
27. A Nathan L Goodyer A Lovejoy A Rashid 1999 Brown bag medication reviews as a means of optimizing patients' use of medication and identifying potential clinical problems Fam Pract 16 278 282 1:STN:280:DyaK1MzmvVymtw%3D%3D 10.1093/fampra/16.3.278 10439982 (Pubitemid 29346911)
28. A Nguyen K Yu S Shakib, et al. 2007 Classification of findings in the home medicines reviews of post-discharge patients at risk of medication misadventure J Pharm Pract Res 37 111 114
29. PS Nishtala AJ McLachlan JS Bell TF Chen 2008 Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions Am J Geriatr Psychiatry 16 621 632 10.1097/JGP.0b013e31817c6abe 18669940
30. J Pirkis P Burgess T Coombs, et al. 2005 Routine measurement of outcomes in Australia's public sector mental health services Aust New Zealand Health Policy 2 8 10.1186/1743-8462-2-8 15840170 (Pubitemid 44848561)
31. M Pirmohamed S James S Meakin, et al. 2004 Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients Br Med J 329 15 19 10.1136/bmj.329.7456.15 (Pubitemid 38869995)
32. MS Roberts JA Stokes MA King, et al. 2001 Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes Br J Clin Pharmacol 51 257 265 1:STN:280:DC%2BD3M3gvV2mug%3D%3D 10.1046/j.1365-2125. 2001.00347.x 11298072 (Pubitemid 32396417)
33. A Rosen 2006 The community psychiatrist of the future Curr Opin Psychiatry 19 380 388 10.1097/01.yco.0000228758.18109.22 16721168 (Pubitemid 44317864)
34. A Rosen T Callaly 2005 Interdisciplinary teamwork and leadership: issues for psychiatrists Australas Psychiatry 13 234 240 16174195
35. JM Rothschild K Mann CA Keohane, et al. 2007 Medication safety in a psychiatric hospital Gen Hosp Psychiatry 29 156 162 10.1016/j.genhosppsych.2006. 12.002 17336665 (Pubitemid 46321635)
36. EE Roughead JD Barratt AL Gilbert 2004 Medication-related problems commonly occurring in an Australian community setting Pharmacoepidemiol Drug Saf 13 83 87 1:STN:280:DC%2BD2c7gslOiug%3D%3D 10.1002/pds.912 14998069 (Pubitemid 38247896)
37. Roughead EE, Barratt JD, Ramsay E et al (2009) The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study. Circ Heart Fail 2:424-428
38. D Ruschena PE Mullen P Burgess, et al. 1998 Sudden death in psychiatric patients Br J Psychiatry 172 331 336 1:STN:280:DyaK1czotFWhtw%3D%3D 10.1192/bjp.172.4.331 9715336
39. Sheskin DJ (2007) Handbook of parametric and nonparametric statistical procedures, 4th edn. Chapman & Hall/CRC, Boca Raton, pp 1387-1401
40. Siegal S, Castellan NJ Jr (1988) Nonparametric statistics for the behavioural sciences, 2nd edn. McGraw-Hill, New York, pp 262-272
41. MA Smith JM Simpson SI Benrimoj 2002 General practitioner acceptance of medication review in Sydney nursing homes J Pharm Pract Res 32 227 231
42. B Soendergaard B Kirkeby C Dinsen H Herborg P Staehr 2006 Drug-related problems in general practice: results from a development project in Denmark Pharm World Sci 28 61 64 10.1007/s11096-006-9008-8 16947067 (Pubitemid 44510948)
43. L Sorensen JA Stokes DM Purdie, et al. 2004 Medication reviews in the community: results of a randomized, controlled effectiveness trial Br J Clin Pharmacol 58 648 664 10.1111/j.1365-2125.2004.02220.x 15563363 (Pubitemid 39665152)
44. A Spinewine KE Schmader N Barber, et al. 2007 Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 370 173 184 10.1016/S0140-6736(07)61091-5 17630041 (Pubitemid 47049724)
45. C Tranulis L Skalli P Lalonde L Nicole E Stip 2008 Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature Drug Saf 31 7 20 1:CAS:528:DC%2BD1cXisFCit7s%3D 10.2165/00002018-200831010-00002 18095743
46. WHO Collaborating Centre for Drug Statistics Methodology (2008) The anatomical therapeutic chemical classification system. WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health, Oslo
47. World Health Organization (2007) International statistical classification of diseases and related health problems (10th revision). http://apps.who.int/ classifications/apps/icd/icd10online/ Accessed 14 September 2009